Trial intelligence / Profile preview

Montelukast add-on therapy for Henoch-Schonlein purpura

ChiCTR-TRC-12002597Phase 4Completed

Sponsor
Jiangsu Provincial People's Hospital
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of montelukast in Henoch-Schönlein Purpura (HSP) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Severity Scale Score for severity ratings of HSP. Started Sep 2014; status: completed.

02

Drugs

montelukast
03

Conditions

Henoch-Schönlein Purpura (HSP)

Beyond the preview

Go deeper on ChiCTR-TRC-12002597.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002597.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call